Ireland
· Delayed Price · Currency is EUR hVIVO Company Description
hVIVO plc operates as a pharmaceutical service and contract research company.
The company is involved in testing of vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations.
The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
In addition, it offers specialized virology and immunology laboratory, which offers a suite of services to support pre-clinical and clinical respiratory drug; and vaccine discovery and development.
Further, the company provides preclinical and early clinical research services; sales and marketing services; data management; and statistics services, as well as drug development consultancy and services.
The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
| Country | United Kingdom |
| Industry | Commercial Physical and Biological Research |
| Employees | 274 |
| CEO | Yamin Khan |
Contact Details
Address: 21 Plumbers Row London, E1 1EQ United Kingdom | |
| Phone | 44 20 7756 1300 |
| Website | hvivo.com |
Stock Details
| Ticker Symbol | HVO |
| Exchange | Euronext Dublin |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| SIC Code | 8731 |